Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 11 | 2026 | 439 | 3.720 |
Why?
|
| Osteoporosis | 5 | 2025 | 73 | 2.430 |
Why?
|
| Bone Density | 15 | 2025 | 146 | 2.150 |
Why?
|
| Familial Hypophosphatemic Rickets | 3 | 2023 | 4 | 2.140 |
Why?
|
| Bone Matrix | 4 | 2017 | 18 | 1.880 |
Why?
|
| Anti-HIV Agents | 4 | 2025 | 63 | 1.780 |
Why?
|
| Bone and Bones | 9 | 2023 | 107 | 1.760 |
Why?
|
| Weight Gain | 2 | 2025 | 61 | 1.760 |
Why?
|
| Animals | 29 | 2025 | 3271 | 1.600 |
Why?
|
| Osteolysis | 6 | 2025 | 113 | 1.370 |
Why?
|
| Biomarkers | 8 | 2022 | 483 | 1.330 |
Why?
|
| Osteocalcin | 6 | 2025 | 26 | 1.320 |
Why?
|
| X-Ray Microtomography | 10 | 2023 | 74 | 1.140 |
Why?
|
| Bone Remodeling | 4 | 2021 | 48 | 1.110 |
Why?
|
| Anti-Retroviral Agents | 2 | 2025 | 15 | 1.110 |
Why?
|
| Mice | 13 | 2025 | 1240 | 1.090 |
Why?
|
| Calcium, Dietary | 2 | 2018 | 12 | 1.090 |
Why?
|
| Female | 22 | 2026 | 13133 | 1.080 |
Why?
|
| Arthroplasty, Replacement | 3 | 2025 | 124 | 1.060 |
Why?
|
| Parathyroid Hormone | 3 | 2021 | 24 | 1.050 |
Why?
|
| Glycoproteins | 3 | 2018 | 41 | 1.020 |
Why?
|
| Implants, Experimental | 3 | 2021 | 32 | 0.980 |
Why?
|
| Hormones | 1 | 2025 | 14 | 0.930 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2025 | 4 | 0.910 |
Why?
|
| Adenine | 1 | 2025 | 3 | 0.900 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2025 | 60 | 0.900 |
Why?
|
| Tenofovir | 1 | 2025 | 2 | 0.900 |
Why?
|
| Alzheimer Disease | 3 | 2026 | 1414 | 0.900 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2025 | 684 | 0.900 |
Why?
|
| Cognitive Dysfunction | 2 | 2026 | 806 | 0.900 |
Why?
|
| Interleukin-6 | 1 | 2025 | 70 | 0.890 |
Why?
|
| Fatty Acids | 1 | 2025 | 33 | 0.890 |
Why?
|
| Intra-Abdominal Fat | 1 | 2025 | 41 | 0.870 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2025 | 176 | 0.860 |
Why?
|
| Humans | 29 | 2026 | 23178 | 0.840 |
Why?
|
| Male | 23 | 2026 | 12650 | 0.820 |
Why?
|
| Tooth | 1 | 2023 | 1 | 0.820 |
Why?
|
| Osseointegration | 3 | 2021 | 69 | 0.800 |
Why?
|
| Fractures, Bone | 2 | 2022 | 70 | 0.790 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2023 | 9 | 0.770 |
Why?
|
| Signal Transduction | 1 | 2025 | 387 | 0.770 |
Why?
|
| Bone Development | 1 | 2023 | 29 | 0.760 |
Why?
|
| Joint Prosthesis | 2 | 2020 | 69 | 0.720 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2018 | 45 | 0.710 |
Why?
|
| Lactation | 2 | 2018 | 51 | 0.680 |
Why?
|
| HIV Seropositivity | 1 | 2021 | 50 | 0.670 |
Why?
|
| Prosthesis Retention | 1 | 2020 | 4 | 0.660 |
Why?
|
| Bone-Implant Interface | 1 | 2020 | 7 | 0.660 |
Why?
|
| Osteoporotic Fractures | 2 | 2025 | 14 | 0.630 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2021 | 314 | 0.600 |
Why?
|
| Bone Regeneration | 5 | 2021 | 67 | 0.590 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 5 | 0.580 |
Why?
|
| Minerals | 1 | 2018 | 6 | 0.580 |
Why?
|
| Weaning | 1 | 2018 | 6 | 0.580 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2025 | 560 | 0.570 |
Why?
|
| Titanium | 2 | 2021 | 139 | 0.560 |
Why?
|
| Rats | 10 | 2021 | 622 | 0.560 |
Why?
|
| Osteogenesis | 4 | 2021 | 99 | 0.550 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2025 | 46 | 0.540 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2016 | 2 | 0.490 |
Why?
|
| Phosphates | 3 | 2021 | 16 | 0.480 |
Why?
|
| Mutation | 1 | 2016 | 330 | 0.430 |
Why?
|
| Antibodies | 1 | 2014 | 43 | 0.420 |
Why?
|
| Calcitonin | 1 | 2014 | 9 | 0.420 |
Why?
|
| Fracture Fixation | 1 | 2014 | 21 | 0.420 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 14 | 0.410 |
Why?
|
| Diphosphonates | 1 | 2014 | 16 | 0.410 |
Why?
|
| Absorptiometry, Photon | 3 | 2023 | 86 | 0.380 |
Why?
|
| Middle Aged | 6 | 2026 | 7972 | 0.380 |
Why?
|
| Aged | 6 | 2026 | 7653 | 0.380 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 226 | 0.380 |
Why?
|
| Disease Models, Animal | 4 | 2025 | 526 | 0.360 |
Why?
|
| Femur | 5 | 2021 | 298 | 0.350 |
Why?
|
| Graft vs Host Disease | 2 | 2022 | 53 | 0.340 |
Why?
|
| PHEX Phosphate Regulating Neutral Endopeptidase | 2 | 2021 | 3 | 0.330 |
Why?
|
| Fibroblast Growth Factors | 2 | 2021 | 5 | 0.330 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2022 | 104 | 0.330 |
Why?
|
| Prosthesis Failure | 3 | 2020 | 411 | 0.310 |
Why?
|
| Bone Diseases, Metabolic | 2 | 2023 | 17 | 0.310 |
Why?
|
| Wnt Signaling Pathway | 2 | 2021 | 30 | 0.310 |
Why?
|
| Mice, Transgenic | 2 | 2023 | 175 | 0.300 |
Why?
|
| Polyethyleneimine | 3 | 2015 | 6 | 0.250 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2026 | 7 | 0.250 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2016 | 8 | 0.240 |
Why?
|
| Marijuana Use | 1 | 2025 | 2 | 0.240 |
Why?
|
| Proteomics | 1 | 2026 | 61 | 0.240 |
Why?
|
| Cross-Sectional Studies | 3 | 2026 | 778 | 0.230 |
Why?
|
| Lipocalin-2 | 1 | 2025 | 2 | 0.230 |
Why?
|
| Alanine | 1 | 2025 | 12 | 0.220 |
Why?
|
| Adult | 4 | 2025 | 6951 | 0.220 |
Why?
|
| Lipid Metabolism | 1 | 2025 | 35 | 0.220 |
Why?
|
| Accidental Falls | 1 | 2026 | 105 | 0.220 |
Why?
|
| Aged, 80 and over | 2 | 2026 | 3864 | 0.220 |
Why?
|
| Calcium | 2 | 2018 | 370 | 0.220 |
Why?
|
| Alleles | 1 | 2025 | 172 | 0.220 |
Why?
|
| Skull | 2 | 2015 | 16 | 0.220 |
Why?
|
| Tissue Scaffolds | 2 | 2014 | 21 | 0.210 |
Why?
|
| Periodontal Ligament | 1 | 2023 | 1 | 0.210 |
Why?
|
| Biomechanical Phenomena | 3 | 2020 | 537 | 0.200 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2023 | 7 | 0.190 |
Why?
|
| Cardiovascular Diseases | 1 | 2026 | 295 | 0.190 |
Why?
|
| Osteocytes | 2 | 2019 | 18 | 0.190 |
Why?
|
| Prostheses and Implants | 2 | 2014 | 131 | 0.190 |
Why?
|
| Cartilage | 1 | 2022 | 70 | 0.180 |
Why?
|
| Hypogonadism | 1 | 2021 | 6 | 0.180 |
Why?
|
| Infertility | 1 | 2021 | 7 | 0.180 |
Why?
|
| Emtricitabine | 1 | 2021 | 2 | 0.180 |
Why?
|
| Testicular Neoplasms | 1 | 2021 | 20 | 0.180 |
Why?
|
| Femur Neck | 1 | 2021 | 14 | 0.180 |
Why?
|
| Rats, Zucker | 1 | 2021 | 7 | 0.170 |
Why?
|
| Neutron Diffraction | 1 | 2021 | 2 | 0.170 |
Why?
|
| Ovariectomy | 1 | 2021 | 26 | 0.170 |
Why?
|
| Laboratories | 1 | 2021 | 11 | 0.170 |
Why?
|
| Collagen Type I | 1 | 2021 | 14 | 0.170 |
Why?
|
| HIV-1 | 1 | 2023 | 203 | 0.170 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2021 | 49 | 0.170 |
Why?
|
| Risk Assessment | 2 | 2025 | 550 | 0.170 |
Why?
|
| Azepines | 1 | 2021 | 2 | 0.170 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2021 | 8 | 0.170 |
Why?
|
| Viral Load | 1 | 2021 | 70 | 0.170 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2021 | 22 | 0.170 |
Why?
|
| Chondrosarcoma | 1 | 2021 | 38 | 0.170 |
Why?
|
| Triazoles | 1 | 2021 | 28 | 0.170 |
Why?
|
| Plasmids | 3 | 2015 | 42 | 0.160 |
Why?
|
| Adipose Tissue | 1 | 2021 | 73 | 0.160 |
Why?
|
| Transcription Factors | 1 | 2021 | 149 | 0.160 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 442 | 0.160 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 917 | 0.150 |
Why?
|
| Bone Neoplasms | 1 | 2021 | 118 | 0.150 |
Why?
|
| Body Weight | 1 | 2019 | 129 | 0.150 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2017 | 62 | 0.150 |
Why?
|
| Collagen | 2 | 2016 | 81 | 0.150 |
Why?
|
| Porosity | 1 | 2018 | 54 | 0.140 |
Why?
|
| Aging | 1 | 2026 | 1180 | 0.140 |
Why?
|
| Syndactyly | 1 | 2018 | 1 | 0.140 |
Why?
|
| Hyperostosis | 1 | 2018 | 1 | 0.140 |
Why?
|
| Anabolic Agents | 1 | 2018 | 3 | 0.140 |
Why?
|
| Memory, Short-Term | 1 | 2018 | 81 | 0.140 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 123 | 0.130 |
Why?
|
| Double-Blind Method | 1 | 2018 | 374 | 0.130 |
Why?
|
| Pregnancy | 1 | 2018 | 324 | 0.130 |
Why?
|
| Prevalence | 1 | 2018 | 380 | 0.130 |
Why?
|
| Comorbidity | 1 | 2018 | 429 | 0.130 |
Why?
|
| Cortical Bone | 1 | 2017 | 3 | 0.130 |
Why?
|
| Gene Transfer Techniques | 2 | 2015 | 29 | 0.130 |
Why?
|
| Radiography | 1 | 2018 | 521 | 0.130 |
Why?
|
| X-Rays | 1 | 2016 | 6 | 0.120 |
Why?
|
| Independent Living | 1 | 2018 | 240 | 0.120 |
Why?
|
| Point Mutation | 1 | 2016 | 25 | 0.120 |
Why?
|
| Prognosis | 1 | 2018 | 730 | 0.120 |
Why?
|
| Cognition | 1 | 2022 | 1026 | 0.120 |
Why?
|
| Regression Analysis | 1 | 2016 | 216 | 0.120 |
Why?
|
| RNA | 1 | 2015 | 28 | 0.120 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 804 | 0.120 |
Why?
|
| Genotype | 1 | 2016 | 265 | 0.110 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2015 | 43 | 0.110 |
Why?
|
| Phenotype | 1 | 2016 | 260 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 363 | 0.110 |
Why?
|
| Mice, Knockout | 1 | 2015 | 276 | 0.110 |
Why?
|
| Copper | 1 | 2014 | 15 | 0.110 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2015 | 36 | 0.110 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2014 | 10 | 0.110 |
Why?
|
| Chitosan | 1 | 2014 | 13 | 0.110 |
Why?
|
| Microvessels | 1 | 2014 | 12 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 70 | 0.110 |
Why?
|
| Diaphyses | 1 | 2014 | 5 | 0.110 |
Why?
|
| Organ Specificity | 1 | 2014 | 32 | 0.110 |
Why?
|
| Macaca fascicularis | 1 | 2014 | 25 | 0.110 |
Why?
|
| Fracture Healing | 1 | 2014 | 31 | 0.110 |
Why?
|
| Methamphetamine | 1 | 2014 | 22 | 0.110 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 69 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 69 | 0.110 |
Why?
|
| Joints | 1 | 2014 | 67 | 0.110 |
Why?
|
| Models, Animal | 1 | 2014 | 103 | 0.110 |
Why?
|
| Orthopedic Fixation Devices | 1 | 2014 | 19 | 0.100 |
Why?
|
| Corpus Striatum | 1 | 2014 | 63 | 0.100 |
Why?
|
| Thiophenes | 1 | 2014 | 11 | 0.100 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2013 | 4 | 0.100 |
Why?
|
| Humerus | 1 | 2014 | 89 | 0.100 |
Why?
|
| Bone Resorption | 1 | 2014 | 75 | 0.100 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 294 | 0.100 |
Why?
|
| Tibia | 1 | 2014 | 197 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 598 | 0.090 |
Why?
|
| Bone Marrow | 2 | 2022 | 61 | 0.090 |
Why?
|
| Rats, Inbred F344 | 3 | 2015 | 33 | 0.080 |
Why?
|
| United States | 2 | 2026 | 1801 | 0.080 |
Why?
|
| DNA | 3 | 2015 | 94 | 0.080 |
Why?
|
| Lumbar Vertebrae | 1 | 2014 | 354 | 0.080 |
Why?
|
| Calcification, Physiologic | 2 | 2019 | 17 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 2 | 2021 | 90 | 0.070 |
Why?
|
| Quality of Life | 2 | 2022 | 564 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2021 | 164 | 0.060 |
Why?
|
| Risk Factors | 2 | 2026 | 2020 | 0.060 |
Why?
|
| Qualitative Research | 1 | 2025 | 94 | 0.060 |
Why?
|
| Interviews as Topic | 1 | 2025 | 112 | 0.060 |
Why?
|
| Motivation | 1 | 2025 | 83 | 0.060 |
Why?
|
| Cell Survival | 2 | 2015 | 99 | 0.050 |
Why?
|
| Genetic Therapy | 2 | 2015 | 83 | 0.050 |
Why?
|
| Lamivudine | 1 | 2023 | 7 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 47 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2022 | 39 | 0.050 |
Why?
|
| Transplant Recipients | 1 | 2022 | 21 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2026 | 1467 | 0.040 |
Why?
|
| Isotopes | 1 | 2021 | 4 | 0.040 |
Why?
|
| Neutrons | 1 | 2021 | 4 | 0.040 |
Why?
|
| Immunoassay | 1 | 2021 | 33 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2021 | 25 | 0.040 |
Why?
|
| Cellular Senescence | 1 | 2021 | 15 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 21 | 0.040 |
Why?
|
| Proteins | 1 | 2021 | 51 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 31 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 1106 | 0.040 |
Why?
|
| Disease Progression | 1 | 2022 | 547 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 243 | 0.040 |
Why?
|
| Surface Properties | 1 | 2019 | 103 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 85 | 0.040 |
Why?
|
| Polyethylene | 1 | 2019 | 93 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2018 | 2943 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 2 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2018 | 30 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 17 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 578 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2018 | 64 | 0.030 |
Why?
|
| Motor Activity | 1 | 2019 | 274 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2018 | 144 | 0.030 |
Why?
|
| Spine | 1 | 2018 | 98 | 0.030 |
Why?
|
| Craniocerebral Trauma | 1 | 2015 | 5 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2015 | 17 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2015 | 32 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2015 | 49 | 0.030 |
Why?
|
| Receptors, Endothelin | 1 | 2014 | 3 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2014 | 5 | 0.030 |
Why?
|
| Vasoconstriction | 1 | 2014 | 14 | 0.030 |
Why?
|
| Self Administration | 1 | 2014 | 16 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 8 | 0.030 |
Why?
|
| Corrosion | 1 | 2014 | 86 | 0.030 |
Why?
|
| Hypoxia | 1 | 2014 | 30 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2014 | 129 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2014 | 70 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2015 | 369 | 0.030 |
Why?
|
| Transfection | 1 | 2013 | 115 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 80 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2013 | 55 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2014 | 382 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 180 | 0.020 |
Why?
|